Denali Therapeutics Stock Quote DNLI - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

24.09

Bid

23.62

Ask

24.99

Volume

893,489

23.50 Day's Range 24.80

14.56 52 Week Range 28.75

Market Cap

3.435B

Previous Close

23.61

Open

23.78

Last Trade

24.03

Last Trade Time

16:19:12

Financial Volume

$ 21,782,532

VWAP

24.3792

Average Volume (3m)

1,155,947

Shares Outstanding

142,609,036

Dividend Yield

PE Ratio

-23.66

Earnings Per Share (EPS)

-1.02

Revenue

330.53M

Net Profit

-145.22M

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.denalitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $23.61. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 28.75.

Denali Therapeutics currently has 142,609,036 shares outstanding. The market capitalization of Denali Therapeutics is $3.37 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -23.66.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological products for rare diseasesDNL126 was selected...

Form 8-K - Current report

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.37	6.02992957746	22.72	24.8	21.23	1270785	23.1571003	CS
4	2.06	9.3508851566	22.03	24.8	20.43	1100057	22.59063482	CS
12	7.68	46.8007312614	16.41	24.8	15.92	1155947	21.04184104	CS
26	6.79	39.2485549133	17.3	24.8	14.56	1194968	19.63868316	CS
52	-4.28	-15.0863588297	28.37	28.75	14.56	1028659	20.14609588	CS
156	-27.39	-53.2051282051	51.48	57.48	14.56	769810	27.28538951	CS
260	3.47	16.8283220175	20.62	93.94	12.39	685307	32.19614467	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BFIBurgerFi International Inc	$ 0.5141 (141.25%)	12M
WINTWindtree Therapeutics Inc	$ 4.60 (39.82%)	364.99k
SPECSpectaire Holdings Inc	$ 0.5459 (36.48%)	5.45M
CLLSCellectis SA	$ 2.34 (14.15%)	327.39k
NUVOHoldco Nuvo Group DG Ltd	$ 0.80 (13.80%)	45.95k
DXCMDexCom Inc	$ 72.40 (-32.87%)	2.93M
ZYXIZynex Inc	$ 8.70 (-14.62%)	13.87k
JEWLAdamas One Corporation	$ 0.366 (-10.95%)	1.2k
NVNINVNI Group Ltd	$ 1.7065 (-9.71%)	181.96k
TNDMTandem Diabetes Care Inc	$ 37.00 (-8.98%)	76.52k
BFIBurgerFi International Inc	$ 0.5141 (141.25%)	12M
SPECSpectaire Holdings Inc	$ 0.5459 (36.48%)	5.45M
NVDANVIDIA Corporation	$ 111.56 (-0.64%)	3.86M
DXCMDexCom Inc	$ 72.40 (-32.87%)	2.93M
QDELQuidelOrtho Corporation	$ 38.24 (0.00%)	2.69M